These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7505056)

  • 21. c-erbB-2 oncoprotein expression in primary human tumors.
    McCann A; Dervan PA; Johnston PA; Gullick WJ; Carney DN
    Cancer; 1990 Jan; 65(1):88-92. PubMed ID: 2403483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
    Chiu KY; Loke SL; Ho FC
    J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate.
    Ware JL; Maygarden SJ; Koontz WW; Strom SC
    Hum Pathol; 1991 Mar; 22(3):254-8. PubMed ID: 1672281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu.
    Myers JN; Drebin JA; Wada T; Greene MI
    Methods Enzymol; 1991; 198():277-90. PubMed ID: 1677444
    [No Abstract]   [Full Text] [Related]  

  • 26. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the c-erbB-2 protein in normal and transformed cells.
    Gullick WJ; Berger MS; Bennett PL; Rothbard JB; Waterfield MD
    Int J Cancer; 1987 Aug; 40(2):246-54. PubMed ID: 3301694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
    Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
    J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
    Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
    Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
    Bacus SS; Stancovski I; Huberman E; Chin D; Hurwitz E; Mills GB; Ullrich A; Sela M; Yarden Y
    Cancer Res; 1992 May; 52(9):2580-9. PubMed ID: 1373672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia.
    Asadi F; Farraj M; Sharifi R; Malakouti S; Antar S; Kukreja S
    Hum Pathol; 1996 Dec; 27(12):1319-23. PubMed ID: 8958305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer.
    Dawson DM; Lawrence EG; MacLennan GT; Amini SB; Kung HJ; Robinson D; Resnick MI; Kursh ED; Pretlow TP; Pretlow TG
    J Natl Cancer Inst; 1998 Apr; 90(7):519-23. PubMed ID: 9539247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of c-erbB-2 expression by neoplastic human tissue using monospecific and bispecific monoclonal antibodies.
    Garcia de Palazzo I; Klein-Szanto A; Weiner LM
    Int J Biol Markers; 1993; 8(4):233-9. PubMed ID: 7908024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate].
    Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.
    Tauchi K; Hori S; Itoh H; Osamura RY; Tokuda Y; Tajima T
    Virchows Arch A Pathol Anat Histopathol; 1989; 416(1):65-73. PubMed ID: 2573192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
    Weiner DB; Nordberg J; Robinson R; Nowell PC; Gazdar A; Greene MI; Williams WV; Cohen JA; Kern JA
    Cancer Res; 1990 Jan; 50(2):421-5. PubMed ID: 1967224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.